A
JAZZ icon

AustralianSuper’s Jazz Pharmaceuticals JAZZ Stock Holding History

AustralianSuper’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-95,631
Closed -$10.2M – 249
2024
Q2 		$10.2M Buy
95,631
+40,302
+73% +$4.43M 0.06% 97
2024
Q1 		$6.58M Buy
+55,329
New +$6.78M 0.04% 135
2023
Q2 		– Sell
-41,937
Closed -$6.14M – 284
2023
Q1 		$6.14M Buy
+41,937
New +$6.2M 0.04% 152
2022
Q3 		– Sell
-56,832
Closed -$8.87M – 171
2022
Q2 		$8.87M Sell
56,832
-63,358
-53% -$9.75M 0.05% 161
2022
Q1 		$18.7M Sell
120,190
-36,440
-23% -$5.29M 0.1% 128
2021
Q4 		$20.3M Buy
156,630
+14,293
+10% +$1.88M 0.11% 118
2021
Q3 		$18.5M Buy
142,337
+7,509
+6% +$1.13M 0.12% 117
2021
Q2 		$24M Buy
134,828
+44,884
+50% +$7.77M 0.17% 82
2021
Q1 		$14.8M Buy
89,944
+72,189
+407% +$11.9M 0.12% 107
2020
Q4 		$2.93M Buy
17,755
+7,644
+76% +$1.14M 0.02% 128
2020
Q3 		$1.44M Buy
+10,111
New +$1.25M 0.01% 135

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

AustralianSuper's JAZZ Position: Q3 2024 in Review

AustralianSuper sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2024, closing a stake of 95,631 shares — an estimated $10.2M sold.

AustralianSuper first reported a position in JAZZ in Q3 2020 and held it in 11 quarters. The position peaked at $24M in Q2 2021. 478 funds tracked by Wall St. Rank hold JAZZ as of Q3 2024.

  • AustralianSuper reported no remaining Jazz Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • AustralianSuper sold 95,631 Jazz Pharmaceuticals shares in Q3 2024, an estimated $10.2M.
  • AustralianSuper first reported a position in Jazz Pharmaceuticals in Q3 2020 and held it in 11 quarters.
  • AustralianSuper's Jazz Pharmaceuticals position peaked at $24M in Q2 2021.
  • 478 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2024.

Based on AustralianSuper's 13F filing for Q3 2024, filed 28 Oct 2024.